In a series of CCl4-induced liver fibrosis studies, silymarin significantly decreased connective tissue growth factor (CTGF), regulated Kupffer cells, inhibited inflammation via NF-κB signaling, and suppressed the activation of HSCs [29–31]. Here, NFKB1 is linked to Hepatic fibrosis.